- Home
- MIRM vs GGAL Comparison
MIRM vs GGAL Comparison
Compare MIRM & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | GGAL |
|---|---|---|
| Founded | 2018 | 1905 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.0B |
| IPO Year | 2019 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MIRM | GGAL |
|---|---|---|
| Price | $82.85 | $36.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | ★ $153.07 | $65.50 |
| AVG Volume (30 Days) | 732.8K | ★ 917.8K |
| Earning Date | 11-03-2026 | 03-07-2023 |
| Dividend Yield | N/A | ★ 4.32% |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $33.62 | $40.83 |
| Revenue Next Year | $17.72 | $25.56 |
| P/E Ratio | ★ N/A | $13.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.23 | $34.57 |
| 52 Week High | $130.00 | $62.11 |
Technical Indicators
Market Signals| Indicator | MIRM | GGAL |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 38.69 |
| Support Level | $78.07 | $35.21 |
| Resistance Level | $88.31 | $45.33 |
| Average True Range (ATR) | 3.94 | 1.23 |
| MACD | 0.69 | 0.19 |
| Stochastic Oscillator | 46.34 | 30.80 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. The company generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.